The ruling means that small-scale compounders must immediately stop making their versions of Novo’s Ozempic and Wegovy, while ...

Despite the decision being a win for Novo Nordisk, the compounded drugs sector is far too complex for this to be a final ...

Novo Nordisk filed for approval of an oral, 25-mg formulation of its weight loss blockbuster “earlier this year,” according ...

Patients flocked to those Ozempic, Wegovy copycats when the branded drugs were in short supply, or if they didn’t have ...

Men, especially, were less likely to agree with medical necessity and more likely to stress the role of personal ...

Mochi Health, one of those implicated, is one of the largest telehealth providers of compounded GLP-1RAs. Eli Lilly maintains ...

A leading GP has said that people ordering illicit weight loss drugs online are "dicing with death" after a BBC investigation ...

The pharmaceutical company that makes the weight-loss drug Wegovy and the diabetes ... to continue selling less expensive copies of semaglutide, Novo Nordisk's blockbuster drug sold under the ...

The General Inspectorate of Health Activities (IGAS) has opened a clarification process regarding the marketing of the drug ...

A federal judge rejected a bid by compounding pharmacies to continue selling versions of weight-loss drug Wegovy and diabetes ...